🕶️ Zuckerberg on trial, Musk eyes IPO

Outpost Bio has raised $3.5 million in pre-seed funding, co-led by Merantix Capital and Seedcamp, to build AI-driven models that decode complex interactions in human microbiology. Through its “Lab-in-the-Loop” platform, the company combines automated experiments with machine learning to generate proprietary human-derived data, helping pharma reduce clinical risk and design safer drugs, while also supporting food and consumer brands in evaluating how ingredients like prebiotics and botanicals impact microbial communities.

In this episode, we break down the quiet crisis inside America’s power grid: transformer shortages, 7-year interconnection waits, exploding component prices, and a supply chain the country outsourced decades ago. We explain how substations actually work (yes, with a hose), why voltage matters more than current, and how a seemingly boring piece of infrastructure is driving up your electricity bill.

This isn’t just about AI. It’s about how the U.S. treated grid hardware like a commodity instead of a strategic asset — and why that decision could cost the country the AI arms race.

Internal documents revealed during Mark Zuckerberg’s testimony show Instagram tracked rising user time spent, growing from 40 to 46 minutes per day between 2023 and 2026. The data is central to a Los Angeles trial where a 19-year-old plaintiff claims social media addiction harmed her mental health. Meta disputes the claims and says it enforces age restrictions, despite evidence showing millions of under-13 users were on the app years ago.

Plaintiffs argue Meta prioritized increasing teen engagement, citing internal emails referencing “total teen time spent” as a company focus. While Instagram has since introduced teen protections, documents suggest the platform still aims to dominate the teen demographic.